| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TMO | Common Stock | Options Exercise | $2,773,084 | +14,550 | +25% | $190.59 | 73,806 | 01 Nov 2021 | Direct | |
| transaction | TMO | Common Stock | Options Exercise | $1,951,290 | +12,375 | +17% | $157.68 | 86,181 | 01 Nov 2021 | Direct | |
| transaction | TMO | Common Stock | Sale | $986,918 | -1,570 | -1.8% | $628.61 | 84,611 | 01 Nov 2021 | Direct | F1, F2 |
| transaction | TMO | Common Stock | Sale | $1,259,420 | -2,000 | -2.4% | $629.71 | 82,611 | 01 Nov 2021 | Direct | F1, F3 |
| transaction | TMO | Common Stock | Sale | $2,611,687 | -4,141 | -5% | $630.69 | 78,470 | 01 Nov 2021 | Direct | F1, F4 |
| transaction | TMO | Common Stock | Sale | $2,380,953 | -3,769 | -4.8% | $631.72 | 74,701 | 01 Nov 2021 | Direct | F1, F5 |
| transaction | TMO | Common Stock | Sale | $1,497,601 | -2,367 | -3.2% | $632.70 | 72,334 | 01 Nov 2021 | Direct | F1, F6 |
| transaction | TMO | Common Stock | Sale | $3,910,652 | -6,169 | -8.5% | $633.92 | 66,165 | 01 Nov 2021 | Direct | F1, F7 |
| transaction | TMO | Common Stock | Sale | $3,306,204 | -5,209 | -7.9% | $634.71 | 60,956 | 01 Nov 2021 | Direct | F1, F8 |
| transaction | TMO | Common Stock | Sale | $572,202 | -900 | -1.5% | $635.78 | 60,056 | 01 Nov 2021 | Direct | F1, F9 |
| transaction | TMO | Common Stock | Sale | $509,456 | -800 | -1.3% | $636.82 | 59,256 | 01 Nov 2021 | Direct | F1, F10 |
| transaction | TMO | Common Stock | Options Exercise | $2,773,084 | +14,550 | +25% | $190.59 | 73,806 | 02 Nov 2021 | Direct | |
| transaction | TMO | Common Stock | Options Exercise | $1,951,290 | +12,375 | +17% | $157.68 | 86,181 | 02 Nov 2021 | Direct | |
| transaction | TMO | Common Stock | Sale | $316,635 | -500 | -0.58% | $633.27 | 85,681 | 02 Nov 2021 | Direct | F1, F11 |
| transaction | TMO | Common Stock | Sale | $952,635 | -1,500 | -1.8% | $635.09 | 84,181 | 02 Nov 2021 | Direct | F1, F12 |
| transaction | TMO | Common Stock | Sale | $3,182,144 | -5,004 | -5.9% | $635.92 | 79,177 | 02 Nov 2021 | Direct | F1, F13 |
| transaction | TMO | Common Stock | Sale | $2,552,695 | -4,008 | -5.1% | $636.90 | 75,169 | 02 Nov 2021 | Direct | F1, F14 |
| transaction | TMO | Common Stock | Sale | $2,349,153 | -3,682 | -4.9% | $638.01 | 71,487 | 02 Nov 2021 | Direct | F1, F15 |
| transaction | TMO | Common Stock | Sale | $3,668,843 | -5,741 | -8% | $639.06 | 65,746 | 02 Nov 2021 | Direct | F1, F16 |
| transaction | TMO | Common Stock | Sale | $2,462,720 | -3,848 | -5.9% | $640.00 | 61,898 | 02 Nov 2021 | Direct | F1, F17 |
| transaction | TMO | Common Stock | Sale | $1,303,092 | -2,033 | -3.3% | $640.97 | 59,865 | 02 Nov 2021 | Direct | F1, F18 |
| transaction | TMO | Common Stock | Sale | $391,136 | -609 | -1% | $642.26 | 59,256 | 02 Nov 2021 | Direct | F1, F19 |
| holding | TMO | Common Stock | 477 | 01 Nov 2021 | By 401(k) | ||||||
| holding | TMO | Common Stock | 5,320 | 01 Nov 2021 | By Grace S. Stevenson Irrevocable Trust | ||||||
| holding | TMO | Common Stock | 5,320 | 01 Nov 2021 | By Matthew L. Stevenson Irrevocable Trust | ||||||
| holding | TMO | Common Stock | 5,320 | 01 Nov 2021 | By Jack A. Stevenson Irrevocable Trust | ||||||
| holding | TMO | Common Stock | 22,100 | 01 Nov 2021 | By GRAT | ||||||
| holding | TMO | Common Stock | 29,959 | 01 Nov 2021 | By Stevenson 2010 Living Trust |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TMO | Stock Option (Right to Buy) | Options Exercise | $0 | -14,550 | -33% | $0.000000 | 29,100 | 01 Nov 2021 | Common Stock | 14,550 | $190.59 | Direct | |
| transaction | TMO | Stock Option (Right to Buy) | Options Exercise | $0 | -12,375 | -33% | $0.000000 | 24,750 | 01 Nov 2021 | Common Stock | 12,375 | $157.68 | Direct | F20 |
| transaction | TMO | Stock Option (Right to Buy) | Options Exercise | $0 | -14,550 | -50% | $0.000000 | 14,550 | 02 Nov 2021 | Common Stock | 14,550 | $190.59 | Direct | |
| transaction | TMO | Stock Option (Right to Buy) | Options Exercise | $0 | -12,375 | -50% | $0.000000 | 12,375 | 02 Nov 2021 | Common Stock | 12,375 | $157.68 | Direct | F20 |
| Id | Content |
|---|---|
| F1 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 3, 2021. |
| F2 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $628.08 to $629.06, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5), (6), (7), (8), (9), (10), (11), (12), (13), (14), (15), (16), (17), (18) and (19) to this Form 4. |
| F3 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $629.21 to $630.16, inclusive. |
| F4 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $630.23 to $631.15, inclusive. |
| F5 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $631.25 to $632.23, inclusive. |
| F6 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $632.30 to $633.25, inclusive. |
| F7 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $633.31 to $634.30, inclusive. |
| F8 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $634.31 to $635.29, inclusive. |
| F9 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $635.44 to $636.415, inclusive. |
| F10 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $636.70 to $637.215, inclusive. |
| F11 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $632.79 to $633.415, inclusive. |
| F12 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $634.46 to $635.39, inclusive. |
| F13 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $635.46 to $636.44, inclusive. |
| F14 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $636.47 to $637.41, inclusive. |
| F15 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $637.51 to $638.50, inclusive. |
| F16 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $638.51 to $639.47, inclusive. |
| F17 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $639.51 to $640.44, inclusive. |
| F18 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $640.65 to $641.34, inclusive. |
| F19 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $641.99 to $642.88, inclusive. |
| F20 | The option vested in four equal installments on February 28, 2018, 2019, 2020, and 2021. |